Maastricht, 21 May 2019
Medace BV, a unique service provider to bring medical innovations to the patient faster and more efficiently, has raised 7.4 million euros from investors to expand their ambitions. The service model that Medace uses is developed within the Chemelot Institute for Science & Technology (InSciTe). With this model, Medace will establish itself on the Brightlands Maastricht Health Campus as an independent company. Maastricht Holding, LIOF, Maastricht UMC+, Brightlands Health Campus, Brightlands Chemelot Campus and the Province of Limburg provide the financing.
In Medace’s concept, clients are guided to develop their prototype into a medical product themselves. In the new environment, Medace has office infrastructure as well as a complete ISO-certified quality management system for its working environment including cleanrooms, equipment, training and professionals.
From 1 January 2020, Medace will be able to simultaneously service 20 companies and academic developments at the new location. Focused on the development of biomedical materials, implants, cell therapy and combination (regenerative medicine) products, the Medace model is unique for the Netherlands and beyond.
Born out of frustration
The concept of Medace originates from within the facilities of InSciTe. Here researchers and entrepreneurs work side-by-side to translate promising biomedical ideas from the academic setting into new products and therapies for patients. Danielle Curfs, CEO of Medace, explains the emergence of the Medace concept: “Within InSciTe I worked on a daily basis with driven people who became frustrated because of the high development costs and the complex laws and regulations. I saw good ideas left on the shelf. Not because they didn’t work, but because the route to the patient is so complex. That is why we have developed a model in which all the necessary production elements are offered in a selection menu. You take what you need for the phase that the product development is in, from infrastructure to people and everything ISO certified. That way you can serve many more parties faster and with significantly fewer resources. In addition, the learning element is huge because everyone runs into similar problems.”
Emiel Staring, managing director of InSciTe adds enthusiastically: “It is fantastic to see not only our projects but also our working methods lead to new activities. We are now transferring our current facility to a third party and as one of the Medace customers we will continue to execute our projects at the new location.”
Outgrown the cradle
The recognition of the value of this model came quickly and 4 years after the opening of the InSciTe facility in Geleen, there is a need for an independent company with more extensive facilities to serve a greater number of parties. These facilities will be realized on the Brightlands Health Campus in Maastricht. With the help of the municipality of Maastricht, more than 2,000 m2 of lab and clean rooms are being built in an existing building.
Vivianne Heijnen, economics councillor of the municipality of Maastricht explains: “We are very happy with the arrival of Medace in our city. Leading biomedical companies such as these are important for the further growth of the Brightlands Maastricht Health Campus. In collaboration with our Business Contact Point, Medace is transforming part of an empty office building into a high-tech laboratory and research facility. That means not only new jobs, but also more opportunities for our region to retain and attract talent.”
Tys van Elk, managing director of LIOF states: “The beauty of Medace is that it offers a solution for both starting and established entrepreneurs who are looking for a professional environment for medical product development. With Medace, we expect to be able to offer a strong and globally unique concept in this region in collaboration with the Brightlands Maastricht Health Campus and the Brightlands Chemelot Campus.”
“Knowledge valorisation is becoming increasingly important for us as a University as an extension of our academic research. Medace offers us a springboard with which the results of scientific research can be further developed into new medical products and services, ultimately leading to new employment and more economic activity in Limburg and beyond”, according to Wim Bens, CEO UM Holding.
Joost van den Akker, Regional Minister of Economy and Knowledge Infrastructure Province of Limburg concludes: “Medace creates a landing place for new ideas and activities on the Brightlands Maastricht Health Campus. Together with the ideas originating from this Campus, Medace brings these to human application. Once fully grown, they can be produced on a larger scale at the Brightlands Chemelot Campus. With this unique facility, Brightlands strengthens its international competitiveness.”
Danielle Curfs : Chief Executive Officer, Medace
Phone : +31 6 3086 1483
Email : firstname.lastname@example.org
Kurt Gielen : Chief Business Officer, Medace
Phone : +31 6 1927 1669
Email : email@example.com
Website : www.medacespace.com
Images related to this press release can be downloaded free of costs and royalties via WeTransfer.
Ingrid Grimbergen : Communications Manager, Chemelot InSciTe
Phone : +31 6 4635 5171
Email : firstname.lastname@example.org
Website : www.chemelot-inscite.com
Too many promising medical innovations never reach the market or the patient. One of the obstacles is finding a way through the increasingly strict and complex landscape of medical devices and cell therapy (GMP) legislation and technical validation.
Medace offers a full-service work-learning environment in which clients (academics or entrepreneurs) are guided in setting up and developing the technical file needed for clinical validation, while producing their clinical quality product.
Medace works with an EN ISO 13485:2016 certified quality and service package that is available to our customers.
- Specialized infrastructure (including ISO8 and 7, and class C and B clean rooms)
- Validated and specialized equipment
- Office environment
- Quality management system
- Trained professionals for hands-on guidance and support
- Dedicated internal training programs
The Chemelot Institute for Science & Technology (InSciTe) is a public-private research and validation institute for the development of biobased building blocks and biomedical materials that is located on the Brightlands Chemelot Campus in Geleen. The initiators of InSciTe are DSM, Maastricht University and Maastricht University Medical Center, Eindhoven University of Technology and the Province of Limburg. Together with more than 30 other partners, they have joined forces to contribute to the development of sustainable chemical building blocks from biomass and, on the other hand, the translation of biomedical materials into actual products and therapies for high-quality and affordable healthcare. The development and validation of the biomedical service model, the Biomedical Accelerator Matrix (BEAM-NL), is co-funded by the European Regional Development Fund, the Ministry of Economic Affairs and the Province of Limburg in the context of the Operation Program South Netherlands (OPZuid).